263 related articles for article (PubMed ID: 31082341)
1. [Application of heme oxygenase 1 in the diagnosis of non-alcoholic fatty liver disease].
Yuan XW; Li DD; Liu LD; Zhang Y; Zhao W; Cui LY; Yang Y; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):291-297. PubMed ID: 31082341
[No Abstract] [Full Text] [Related]
2. [Value of constructing a non-invasive diagnostic model based on serum heme oxygenase-1 and glucose regulatory protein 78 for non-alcoholic fatty liver disease].
Cao JC; Zhang HK; Liu CM; Zhao SS; Nan YM; Li DD
Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):228-234. PubMed ID: 38584104
[No Abstract] [Full Text] [Related]
3. [Study on plasma Golgi protein 73 and related models in the diagnosis of nonalcoholic fatty liver disease].
Wang YQ; Yuan XW; Li DD; Tang YH; Xue NN; Cui LY; Liu LD; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1170-1176. PubMed ID: 35045632
[No Abstract] [Full Text] [Related]
4. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
[TBL] [Abstract][Full Text] [Related]
6. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
[TBL] [Abstract][Full Text] [Related]
7. Clinical Criteria Correlated with the Incidence of Patients with Non-alcoholic Fatty Liver Disease.
Chien-Min K; Cheng-Chuan L
Ann Clin Lab Sci; 2017 Mar; 47(2):191-200. PubMed ID: 28442522
[TBL] [Abstract][Full Text] [Related]
8. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
9. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
[TBL] [Abstract][Full Text] [Related]
10. [Study on heme oxygenase-1 and HAP model for the diagnosis of chronic hepatitis B-related liver fibrosis].
Xue NN; Yuan XW; Zhao W; Tang YH; Zhang XX; Wang YQ; Zhao DD; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2021 Aug; 29(8):743-747. PubMed ID: 34517454
[No Abstract] [Full Text] [Related]
11. [Correlation between serum uric acid and risk of new-onset nonalcoholic fatty liver disease: a 5-year observational cohort study].
Bai JX; Shu RM; Huang Y; Peng Z
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):271-275. PubMed ID: 29996338
[No Abstract] [Full Text] [Related]
12. A simpler diagnostic formula for screening nonalcoholic fatty liver disease.
Feng G; He N; Zhou YF; Li XP; Niu C; Liu ML; Zhang KL; Li Y; Li YM; Zheng MH; Mi M
Clin Biochem; 2019 Feb; 64():18-23. PubMed ID: 30503530
[TBL] [Abstract][Full Text] [Related]
13. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.
Gao H; Meng J; Xing H; Nie S; Xu M; Zhang S; Jin Y; Sun T; Huang H; Zhang H; Wang D; Liu L
Hum Reprod; 2014 May; 29(5):1058-66. PubMed ID: 24585089
[TBL] [Abstract][Full Text] [Related]
14. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM
Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763
[TBL] [Abstract][Full Text] [Related]
15. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
[TBL] [Abstract][Full Text] [Related]
16. Preliminary Study on Risk Factors for Morbidity of Nonalcoholic Fatty Liver Disease in High-Income Male Population.
Han L; Zhang Y; Yue C; Huang Y; Wu Y; Chen J
J Healthc Eng; 2022; 2022():9331284. PubMed ID: 35251583
[TBL] [Abstract][Full Text] [Related]
17. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
[TBL] [Abstract][Full Text] [Related]
19. Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.
Zheng K; Yin Y; Guo H; Ma L; Liu R; Zhao T; Wei Y; Zhao Z; Cheng W
Front Endocrinol (Lausanne); 2024; 15():1340644. PubMed ID: 38405152
[TBL] [Abstract][Full Text] [Related]
20. Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease.
Kawanaka M; Nishino K; Nakamura J; Urata N; Oka T; Goto D; Suehiro M; Kawamoto H; Yamada G
Ann Hepatol; 2015; 14(6):837-44. PubMed ID: 26436355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
